Hartford Financial Management Inc. lowered its holdings in Danaher Co. (NYSE:DHR) by 0.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,219 shares of the conglomerate’s stock after selling 216 shares during the quarter. Danaher accounts for about 1.5% of Hartford Financial Management Inc.’s holdings, making the stock its 18th biggest position. Hartford Financial Management Inc.’s holdings in Danaher were worth $4,462,000 as of its most recent filing with the SEC.
A number of other institutional investors have also added to or reduced their stakes in DHR. TRUE Private Wealth Advisors purchased a new position in shares of Danaher in the second quarter valued at $95,000. Cohen Lawrence B increased its position in shares of Danaher by 8.9% in the second quarter. Cohen Lawrence B now owns 6,645 shares of the conglomerate’s stock valued at $950,000 after buying an additional 545 shares in the last quarter. Sunbelt Securities Inc. purchased a new position in shares of Danaher in the second quarter valued at $675,000. Chesapeake Wealth Management purchased a new position in shares of Danaher in the second quarter valued at $780,000. Finally, Coastal Investment Advisors Inc. increased its position in shares of Danaher by 12.1% in the second quarter. Coastal Investment Advisors Inc. now owns 1,095 shares of the conglomerate’s stock valued at $154,000 after buying an additional 118 shares in the last quarter. 79.35% of the stock is owned by institutional investors.
Danaher stock opened at $140.54 on Wednesday. The stock has a market cap of $100.65 billion, a PE ratio of 31.09, a PEG ratio of 2.53 and a beta of 0.94. The stock’s 50-day moving average is $141.56. Danaher Co. has a 52 week low of $94.59 and a 52 week high of $145.50. The company has a current ratio of 2.32, a quick ratio of 1.91 and a debt-to-equity ratio of 0.33.
In related news, EVP William K. Daniel sold 164,164 shares of Danaher stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $132.43, for a total transaction of $21,740,238.52. Following the completion of the sale, the executive vice president now owns 194,627 shares in the company, valued at approximately $25,774,453.61. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Brian W. Ellis sold 1,010 shares of Danaher stock in a transaction dated Friday, July 26th. The stock was sold at an average price of $144.04, for a total value of $145,480.40. Following the sale, the insider now owns 20,889 shares of the company’s stock, valued at approximately $3,008,851.56. The disclosure for this sale can be found here. In the last quarter, insiders have sold 392,121 shares of company stock valued at $53,603,339. 11.40% of the stock is currently owned by company insiders.
A number of brokerages have recently weighed in on DHR. Zacks Investment Research upgraded Danaher from a “sell” rating to a “hold” rating in a research report on Monday, May 6th. Argus raised their price target on Danaher to $165.00 and gave the company a “buy” rating in a research report on Tuesday, July 23rd. Piper Jaffray Companies raised their price target on Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Robert W. Baird raised their price target on Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Finally, Royal Bank of Canada set a $134.00 price target on Danaher and gave the company a “hold” rating in a research report on Friday, July 19th. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Danaher currently has an average rating of “Buy” and an average price target of $143.54.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: What is a capital gains distribution?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.